Clinical outcomes and prognostic factors of patients with epithelial ovarian cancer subjected to first-line treatment: a retrospective study of 251 cases

2013 ◽  
Vol 8 (1) ◽  
pp. 91-95 ◽  
Author(s):  
Yunfeng Fu ◽  
Xinyu Wang ◽  
Zimin Pan ◽  
Xing Xie
Keyword(s):  
Ovarian Cancer ◽  
Prognostic Factors ◽  
Retrospective Study ◽  
Epithelial Ovarian Cancer ◽  
Clinical Outcomes ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment

P168 Influence of first-line treatment for epithelial ovarian cancer on the immune system

2019 ◽  
Author(s):  
T Baert ◽  
C Landolfo ◽  
J Ceusters ◽  
G Thirion ◽  
A Van Hoylandt ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Immune System ◽  
Epithelial Ovarian Cancer ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment

Weekly topotecan as first-line treatment for recurrent or persistent epithelial ovarian cancer (EOC)

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 5111-5111
Author(s):  
T. Safra ◽  
J. Menczer ◽  
M. Inbar ◽  
E. En-Shem ◽  
M. Glezerman ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Epithelial Ovarian Cancer ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment

Gemcitabine combined with cisplatin as first-line treatment in patients with epithelial ovarian cancer: a phase II study

2003 ◽  
Vol 91 (1) ◽  
pp. 32-38 ◽  
Author(s):  
D Belpomme ◽  
I Krakowski ◽  
M Beauduin ◽  
T Petit ◽  
J.L Canon ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Epithelial Ovarian Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment
Sign in / Sign up

Export Citation Format

Share Document